Synthesis, biological evaluation and computational studies of novel iminothiazolidinone benzenesulfonamides as potent carbonic anhydrase II and IX inhibitors

被引：28
|
作者：
Mahmood, Shams-ul [1 ]
Saeed, Aamer [1 ]
Bua, Sivia [2 ]
Nocentini, Alessio [2 ,3 ,4 ]
Gratteri, Paola [3 ,4 ]
Supuran, Claudiu T. [2 ]
机构：
[1] Quaid I Azam Univ, Dept Chem, Islamabad 45320, Pakistan
[2] Univ Florence, Dept NEUROFARBA, Pharmaceut & Nutraceut Sect, Via Ugo Schiff 6, I-50019 Florence, Italy
[3] Univ Florence, Dept NEUROFARBA, Sect Pharmaceut & Nutraceut Sci, Lab Mol Modeling Cheminformat,Pole Sci, Via U Schiff 6, I-50019 Florence, Italy
[4] Univ Florence, QSAR, Polo Sci, Via U Schiff 6, I-50019 Florence, Italy
来源：
BIOORGANIC CHEMISTRY | 2018年 / 77卷
关键词：
Carbonic anhydrase; Zinc-binding group; Nanomolar inhibition; Anti-glaucoma; Anti-tumour; ANTICANCER AGENTS; DESIGN; SULFONAMIDES; MOIETIES; DRUG; DERIVATIVES; ACTIVATORS; DISCOVERY; CANCER; BASES;
D O I：
10.1016/j.bioorg.2018.01.031
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
A series of iminothiazolidinone-sulfonamide hybrids (2a-k) was synthesized by heterocyclization of sulfanilamide thioureas with methyl bromoacetate and characterized by spectroscopic techniques, mass and elemental analysis. The synthesized derivatives were screened against four relevant human (h) isoforms of carbonic anydrases (CAs, EC 4.2.1.1) I, II, IV and IX. These enzymes are involved in a variety of diseases, including glaucoma, retinitis pigmentosa, epilepsy, arthritis, and tumors. Derivatives 2a-2k exhibited the best inhibitory activity against the cytosolyc hCA II (Kis are reaching the sub-nanomolar range, 0.41-37.8 nM) and against the tumor-associated isoform hCA IX (Kis are spanning between 24.3 and 368.3 nM). The binding mode of the reported iminothiazolidinone benzenesulfonamides within hCA II and IX catalytic clefts was investigated by docking studies. (C) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码：381 / 386
页数：6
相关论文
共 50 条
  • [21] Synthesis, biological activity and multiscale molecular modeling studies for coumaryl-carboxamide derivatives as selective carbonic anhydrase IX inhibitors
    Kurt, Belma Zengin
    Sonmez, Fatih
    Durdagi, Serdar
    Aksoydan, Busecan
    Salmas, Ramin Ekhteiari
    Angeli, Andrea
    Kucukislamoglu, Mustafa
    Supuran, Claudiu T.
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2017, 32 (01) : 1042 - 1052
  • [22] Development of isatin-functionalized benzenesulfonamides as novel carbonic anhydrase II and VII inhibitors with antiepileptic potential
    Eldehna, Wagdy M.
    El-Hamaky, Anwar A.
    Giovannuzzi, Simone
    Elsayed, Zainab M.
    Alkabbani, Mahmoud Abdelrahman
    Khaleel, Eman F.
    Al-Sanea, Mohammad M.
    Abo-Ashour, Mahmoud F.
    Elnaggar, Yosra S. R.
    Nocentini, Alessio
    Supuran, Claudiu T.
    Tawfik, Haytham O.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2025, 292
  • [23] Synthesis and biological evaluation of coumarin-1,3,4-oxadiazole hybrids as selective carbonic anhydrase IX and XII inhibitors
    Narella, Sridhar Goud
    Shaik, Mohammed Ghouse
    Mohammed, Arifuddin
    Alvala, Mallika
    Angeli, Andrea
    Supuran, Claudiu T.
    BIOORGANIC CHEMISTRY, 2019, 87 : 765 - 772
  • [24] Synthesis, biological evaluation and in silico studies of novel N-substituted phthalazine sulfonamide compounds as potent carbonic anhydrase and acetylcholinesterase inhibitors
    Turkes, Cuneyt
    Arslan, Mustafa
    Demir, Yeliz
    Cocaj, Liridon
    Nixha, Arleta Rifati
    Beydemir, Sukru
    BIOORGANIC CHEMISTRY, 2019, 89
  • [25] Synthesis of novel acyl selenoureido benzensulfonamides as carbonic anhydrase I, II, VII and IX inhibitors
    Angeli, Andrea
    Carta, Fabrizio
    Bartolucci, Gianluca
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (13) : 3567 - 3573
  • [26] Synthesis of benzamide derivatives with thiourea-substituted benzenesulfonamides as carbonic anhydrase inhibitors
    Tugrak, Mehtap
    Gul, Halise Inci
    Demir, Yeliz
    Gulcin, Ilhami
    ARCHIV DER PHARMAZIE, 2021, 354 (02)
  • [27] Design and Synthesis of 3-(Phenylsulfonamido)benzamide Derivatives as Potent Carbonic Anhydrase IX Inhibitors: Biological Evaluations and Molecular Modeling Studies
    Khanfar, Mohammad A.
    Saleh, Mohammad
    MEDICINAL CHEMISTRY, 2025, 21 (02) : 160 - 167
  • [28] Structure-activity relationship with pyrazoline-based aromatic sulfamates as carbonic anhydrase isoforms I, II, IX and XII inhibitors: Synthesis and biological evaluation
    Moi, Davide
    Nocentini, Alessio
    Deplano, Alessandro
    Balboni, Gianfranco
    Supuran, Claudiu T.
    Onnis, Valentina
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 182
  • [29] Sulfonamides incorporating piperazine bioisosteres as potent human carbonic anhydrase I, II, IV and IX inhibitors
    Chiaramonte, Niccolo
    Bua, Silvia
    Angeli, Andrea
    Ferraroni, Marta
    Picchioni, Ilaria
    Bartolucci, Gianluca
    Braconi, Laura
    Dei, Silvia
    Teodori, Elisabetta
    Supuran, Claudiu T.
    Romanelli, Maria Novella
    BIOORGANIC CHEMISTRY, 2019, 91
  • [30] Heterocyclic periphery in the design of carbonic anhydrase inhibitors: 1,2,4-Oxadiazol-5-yl benzenesulfonamides as potent and selective inhibitors of cytosolic hCA II and membrane-bound hCA IX isoforms
    Krasavin, Mikhail
    Shetnev, Anton
    Sharonova, Tatyana
    Baykov, Sergey
    Tuccinardi, Tiziano
    Kalinin, Stanislav
    Angeli, Andrea
    Supuran, Claudiu T.
    BIOORGANIC CHEMISTRY, 2018, 76 : 88 - 97
12345